2013 ASX Announcements
22nd May 2013
Non-Renounceable Rights Issue Share Allotment
22nd May 2013
Notice Under Section 708A(5)(e)
22nd May 2013
Appendix 3Y Change of Director's Interest Notice
22nd May 2013
Appendix 3Y Change of Director's Interest Notice 22May13
21st May 2013
Notification of Subscriptions
1st May 2013
Dispatch of Non-Renounceable Rights Issue Offer Document
18th April 2013
Notice to Eligible Shareholders 18 Apr 2013
18th April 2013
Notice to Ineligible Shareholders
17th April 2013
Rights Issue - Notice Under Section 708AA(2)(f)
17th April 2013
Non-Renounceable Rights Issue Offer - Letter to Option Holders
17th April 2013
Offer Document
16th April 2013
Non Renounceable Pro Rata Rights Issue
16th April 2013
Appendix 3B
26th March 2013
Appendix 3Y
12th March 2013
Change of Director's Interest Notice
1st March 2013
Progen Pharmaceuticals signs License with Medigen Biotech Corp
31st January 2013
Receipt of R&D Tax Incentive Refund
31st January 2013
Qld Storm - Operations Unaffected
11th January 2013
R&D Tax Incentive Refund
2012 ASX Announcements
31st December 2012
Appendix 4D Interim Financial Report
28th December 2012
Progen Pharmaceuticals Ltd signs Binding License Term Sheet
6th December 2012
Appendix 3Yf
4th December 2012
2012 Form 20-F Filed with the US SEC
25th September 2012
Appendix 3Y 25 Sept 12
|